Perspective Two-Phase Biocatalysis in Microﬂuidic Droplets Lanting Xiang 1,2 , Felix Kaspar 3,4, Anett Schallmey 2,3,5 and Iordania Constantinou 1,2,* 1 Institute for Microtechnology, Technische Universität Braunschweig, 38124 Braunschweig, Germany; l.xiang@tu-braunschweig.de 2 Zentrum für Pharmaverfahrenstechnik (PVZ), Technische Universität Braunschweig, 3 38106 Braunschweig, Germany; a.schallmey@tu-braunschweig.de Institute for Biochemistry, Biotechnology and Bioinformatics, Technische Universität Braunschweig, 38106 Braunschweig, Germany; felix.kaspar@tu-braunschweig.de 4 Chair of Bioprocess Engineering, Institute of Biotechnology, Faculty III Process Sciences, 5 Technische Universität Berlin, 13355 Berlin, Germany Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, 38106 Braunschweig, Germany * Correspondence: i.constantinou@tu-braunschweig.de; Tel.: +49-(0)-531-391-9769 Abstract: This Perspective discusses the literature related to two-phase biocatalysis in microﬂuidic droplets. Enzymes used as catalysts in biocatalysis are generally less stable in organic media than in their native aqueous environments; however, chemical and pharmaceutical compounds are often insoluble in water. The use of aqueous/organic two-phase media provides a solution to this problem and has therefore become standard practice for multiple biotransformations. In batch, two-phase biocatalysis is limited by mass transport, a limitation that can be overcome with the use of microﬂuidic systems. Although, two-phase biocatalysis in laminar ﬂow systems has been extensively studied, microﬂuidic droplets have been primarily used for enzyme screening. In this Perspective, we summarize the limited published work on two-phase biocatalysis in microﬂuidic droplets and discuss the limitations, challenges, and future perspectives of this technology. Keywords: microﬂuidics; two-phase biocatalysis; microﬂuidic droplets; enzyme Citation: Xiang, L.; Kaspar, F.; Schallmey, A.; Constantinou, I. Two-Phase Biocatalysis in Microﬂuidic Droplets. Biosensors 2021, 11, 407. https://doi.org/10.3390/ 1. Introduction bios11110407 Received: 8 September 2021 Accepted: 18 October 2021 Published: 21 October 2021 Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional afﬁl- iations. Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). Biocatalysis is an empowering technology in synthetic organic chemistry. The use of enzymes for chemical transformations often grants unparalleled chemo-, regio- and stereoselectivity, and even enables transformations that would be impossible to achieve with conventional chemical methods [1–4]. Owing to these advantages, recent years have witnessed a growing popularity of strategic enzymatic steps in the preparation of phar- maceuticals, natural products, and other ﬁne chemicals [5–10]. By reducing the length of synthetic routes and the demand for laborious puriﬁcation processes, biocatalytic transfor- mations typically exhibit more favorable green chemistry metrics than their corresponding chemical counterparts [11,12]. As such, biocatalysis continues to evolve into the intuitive choice for the development of environmentally friendly chemical processes, both in aca- demic as well as industrial settings [13]. However, the efﬁcient application of enzymes is often hampered by the low water solubility of desired starting materials. As many compounds of interest in organic chemistry exhibit only limited hydrophilicity, substrate loadings in biocatalytic transformations are often restricted to the low millimolar range, far below the desired titers for industrial settings [11]. To increase the substrate concentra- tions and thereby decrease solvent use, several strategies and process designs have been established. Among these, the use of two immiscible liquid phases, an aqueous and a non-aqueous phase, the latter usually comprising an organic solvent [14–16] or ionic liq- uid [17,18], has emerged as an elegant and remarkably versatile approach. The enzymatic reaction typically takes place in the aqueous phase under substrate concentrations near Biosensors 2021, 11, 407. https://doi.org/10.3390/bios11110407 https://www.mdpi.com/journal/biosensors biosensors(cid:1)(cid:2)(cid:3)(cid:1)(cid:4)(cid:5)(cid:6)(cid:7)(cid:8)(cid:1)(cid:1)(cid:2)(cid:3)(cid:4)(cid:5)(cid:6)(cid:7)Biosensors 2021, 11, 407 2 of 13 the solubility limit, while the non-aqueous (commonly organic) phase acts as a substrate reservoir, continuously delivering the substrate to the aqueous phase. At the same time, the non-aqueous phase serves as a product sink, removing the reaction product from the aque- ous phase. Beyond enabling exceptionally high net substrate concentrations, two-phase biocatalysis has several key advantages, including the prevention of inhibition effects or shift of reaction equilibria via continuous product removal, as well as straightforward prod- uct isolation via phase separation [19,20]. Despite these advantages, biphasic processes are yet to become a true standard technique in biocatalysis, as the design of efﬁcient biphasic enzymatic transformations is challenging and requires non-trivial engineering. Another major challenge is the mixing of the two liquid phases which maximizes mass transfer but can also compromise the stability and hence the activity of the enzyme catalyst [21]. Moreover, stable emulsions can form when performing liquid–liquid two-phase reactions in batch under vigorous stirring, complicating phase separation and thus product isolation during subsequent down-stream processing [22]. The aforementioned challenges can be overcome with the use of microﬂuidic systems. 2. Biocatalysis at the Microscale Flow chemistry has been performed in organic chemistry laboratories in academia and industry for the development, optimization, and intensiﬁcation of chemical processes for several decades [23]. More recently, the ﬁrst biocatalytic reactions performed in mi- croﬂuidics were reported [24,25]; however, ﬂow biocatalysis today remains in its infancy compared to ﬂow chemistry. This is surprising considering the many advantages mi- croﬂuidics offer, such as the possibility of continuously operated reactions, much higher surface-to-volume ratios and hence short diffusion paths, and tremendously increased mass and heat transfer rates [26,27]. These advantages are especially promising for liquid– liquid two-phase biocatalytic reactions that are often limited by mass transfer in batch [28]. As different physical effects inﬂuence ﬂuid ﬂow at the microscale compared to larger scales [29], ﬂuid ﬂow regimes unachievable on the macroscale (such as laminar ﬂow) can be achieved in microchannels. Moreover, process development signiﬁcantly beneﬁts from microscale technology due to reduced consumption of reagents and time, speeding up process development and reducing development costs [26]. In the biocatalysis ﬁeld, this has led to the development of microﬂuidics-based screening methods for activity-based screening of metagenomic libraries [30,31] or mutant libraries derived from enzyme evo- lution campaigns [32,33]. Additionally, enzyme characterization and process parameter estimation and optimization are also facilitated by the use of microﬂuidic devices (often mi- croﬂuidic droplets) due to ultra-high throughput and low reagent consumption [23,34–36]. In addition to high-throughput screening and characterization possibilities, miniaturiza- tion provides a tool that allows researchers to gain an understanding of fundamental process principles and reaction characteristics. This is made possible by the fact that experimental conditions can be precisely and independently controlled in microﬂuidic systems. Although some processes optimized at the microscale cannot be directly scaled up, fundamental process understanding gained at the microscale can still facilitate process optimization in the macroscale. Finally, smaller volumes and better spatial and temporal reaction control in microsystems increase safety in biocatalytic reactions that involve, e.g., toxic reagents [37]. 3. Droplet Generation in Microﬂuidic Systems For two-phase biocatalysis in microﬂuidics, the two liquid phases need to be in contact to ensure fast mass transport across the interface. With the absence of turbulence at the microscale, molecular diffusion becomes the dominant mechanism of mass transfer. A liquid–liquid, two-phase ﬂow in microchannels can be achieved through laminar ﬂow or using microﬂuidic droplets. Laminar ﬂow is dominant when Reynold numbers are low and is characterized by ﬂuid streamlines parallel to the channel walls. The two phases ﬂow next to each other Biosensors 2021, 11, 407 3 of 13 in the form of two layers forming one interface (Figure 1a) or three layers forming two interfaces (Figure 1b). Two-layer ﬂow proﬁles are commonly produced using T-junctions and three-layer laminar ﬂow proﬁles using Ψ-junctions. The width of each phase, i.e., the volume each phase occupies in the channel, can be adjusted by changing the ﬂow rate ratio between the two liquids. Such microsystems are often used for two-phase biocatalysis using immiscible hydrophobic substrates, as they provide advantages like short diffusion paths across the aqueous/non-aqueous interface and easy phase separation at the outlets [38,39]. Figure 1. Laminar ﬂow in a microﬂuidic channel: (a) two liquid phases ﬂowing next to each other and forming two layers and one interface; (b) two liquid phases ﬂowing next to each other and forming three layers and two interfaces. The microﬂuidic device architectures used to achieve these ﬂow patterns are shown as inserts. Similar to laminar ﬂows, microﬂuidic droplets have also been employed as a tool for biphasic enzymatic transformations, however, to a much lesser extent. Microﬂuidic droplet formation requires two immiscible ﬂuids (gas–liquid or liquid–liquid), referred to as the continuous phase (medium in which droplets ﬂow) and the dispersed phase (droplets). In the context of two-phase biocatalysis, liquid–liquid droplets are formed using an organic and an aqueous phase. Each microdroplet can be regarded as an independent microreactor, with fast mass transfer taking place across the droplet boundary. In addition to efﬁcient mass transfer, reactions in microﬂuidic droplets can greatly reduce the consump- tion of expensive reagents due to their tiny volumes (commonly pL to nL) and at the same time limit cross-contamination. There are two common droplet geometries; ellipsoidal (Figure 2a) and spherical (Figure 2b). Ellipsoidal droplets can be produced using T-, Y- and Ψ-junctions. They are larger compared to spherical microdroplets and their width is typically determined by the width of the microﬂuidic channel. The ﬂow of large ellipsoidal droplets (slugs) in a microchannel is commonly referred to as slug ﬂow. Spherical micro- droplets are produced using ﬂow focusing or co-ﬂowing microﬂuidic structures and often have diameters much smaller than the width of the microchannel. Device geometries and droplet generation methods are discussed in detail below. Figure 2. (a) Ellipsoidal microdroplet in a microﬂuidic channel/slug ﬂow. (b) Spherical microdroplets in a microﬂuidic channel/droplet ﬂow. The microﬂuidic device architectures used to achieve these ﬂow patterns are shown in the inserts and discussed in detail below. Biosensors 2021, 11, x FOR PEER REVIEW 3 of 14  Laminar flow is dominant when Reynold numbers are low and is characterized by fluid streamlines parallel to the channel walls. The two phases flow next to each other in the form of two layers forming one interface (Figure 1a) or three layers forming two interfaces (Figure 1b). Two‐layer flow profiles are commonly produced using T‐junctions and three‐layer laminar flow profiles using Ψ‐junctions. The width of each phase, i.e., the volume each phase occupies in the channel, can be adjusted by changing the flow rate ratio between the two liquids. Such microsystems are often used for two‐phase biocatalysis using immiscible hydrophobic substrates, as they provide advantages like short diffusion paths across the aqueous/non‐aqueous interface and easy phase separation at the outlets [38,39].     Figure 1. Laminar flow in a microfluidic channel: (a) two liquid phases flowing next to each other and forming two layers and one interface; (b) two liquid phases flowing next to each other and forming three layers and two interfaces. The microfluidic device architectures used to achieve these flow patterns are shown as inserts. Similar to laminar flows, microfluidic droplets have also been employed as a tool for biphasic enzymatic transformations, however, to a much lesser extent. Microfluidic droplet formation requires two immiscible fluids (gas–liquid or liquid–liquid), referred to as the continuous phase (medium in which droplets flow) and the dispersed phase (droplets). In the context of two‐phase biocatalysis, liquid–liquid droplets are formed using an organic and an aqueous phase. Each microdroplet can be regarded as an independent microreactor, with fast mass transfer taking place across the droplet boundary. In addition to efficient mass transfer, reactions in microfluidic droplets can greatly reduce the consumption of expensive reagents due to their tiny volumes (commonly pL to nL) and at the same time limit cross‐contamination. There are two common droplet geometries; ellipsoidal (Figure 2a) and spherical (Figure 2b). Ellipsoidal droplets can be produced using T‐, Y‐ and Ψ‐junctions. They are larger compared to spherical microdroplets and their width is typically determined by the width of the microfluidic channel. The flow of large ellipsoidal droplets (slugs) in a microchannel is commonly referred to as slug flow. Spherical microdroplets are produced using flow focusing or co‐flowing microfluidic structures and often have diameters much smaller than the width of the microchannel. Device geometries and droplet generation methods are discussed in detail below.   Biosensors 2021, 11, x FOR PEER REVIEW 4 of 14      Figure 2. (a) Ellipsoidal microdroplet in a microfluidic channel/slug flow. (b) Spherical micro‐droplets in a microfluidic channel/droplet flow. The microfluidic device architectures used to achieve these flow patterns are shown in the inserts and discussed in detail below. 3.1. Microfluidic Droplet Production and Their Applications in Two‐Phase Biocatalysis Various applications of microfluidic droplets employed in the field of biocatalysis have been reported in the literature. These can be divided into three main categories: (1) microfluidic droplets for ultrahigh‐throughput library screening, (2) microfluidic droplets for enzyme characterization and parameter estimation, and (3) intensification of two‐phase biocatalytic reactions using microfluidic droplets or droplet‐like fluid flows. The first two categories have already been reviewed comprehensively in recent literature and will not be further discussed in this perspective [23,30,33,34]. Herein, we focus on syn‐thetically useful biocatalytic reactions employing two liquid phases, in an effort to high‐light the benefits and limitations associated with droplet microfluidics when used to per‐form these reactions. Before we discuss specific examples of two‐phase biocatalysis in droplets, we offer a relevant introduction into the production technology of droplet mi‐crofluidics. 3.2. Production Technology of Droplet Microfluidics Droplet formation methods can be classified as passive or active. Passive methods primarily use microchannel architecture and flow rates to control the formation of drop‐lets, while active methods employ external force fields (e.g., light, electricity). In droplet‐based biocatalysis, active droplet formation methods are generally avoided as the used external force fields could harm the enzymes or cells used to facilitate the reactions. The most common passive hydrodynamic methods used to produce microdroplets can be cat‐egorized into three groups according to the microchannel architecture: T‐junction, flow‐focusing, and co‐flowing devices. The geometry of the intersection where the two flows meet, the flow rate of each phase and the properties of the fluid (surface tension, viscosity, etc.) determine the local stresses that deform the liquid interface and cause droplet for‐mation.  T‐junction: T‐junctions were first proposed by Thorsen et al. in 2001 [40]. Droplets in this device architecture are formed when two mutually immiscible fluids meet at the T‐shaped microchannel intersection. Under the action of pressure and shear, the continuous phase cuts off the dispersed phase to form droplets. As seen in Figure 3, T‐junctions have a simple architecture and are easy to fabricate, which makes them a popular choice for applications in biocatalysis. However, the droplet width is determined by the width of the microfluidic channel, and therefore, spherical droplets with smaller diameters cannot be produced. This can be a limiting factor when using these devices for two‐phase biocatal‐ysis, as the available droplet surface area can be quite small compared to that of smaller droplets that float in the middle of the channel. This can partly inhibit mass transfer across the droplet interface (e.g., diffusion of substrate from the organic to the aqueous phase), a critical step during biocatalysis.  Biosensors 2021, 11, 407 4 of 13 3.1. Microﬂuidic Droplet Production and Their Applications in Two-Phase Biocatalysis Various applications of microﬂuidic droplets employed in the ﬁeld of biocatalysis have been reported in the literature. These can be divided into three main categories: (1) mi- croﬂuidic droplets for ultrahigh-throughput library screening, (2) microﬂuidic droplets for enzyme characterization and parameter estimation, and (3) intensiﬁcation of two-phase biocatalytic reactions using microﬂuidic droplets or droplet-like ﬂuid ﬂows. The ﬁrst two categories have already been reviewed comprehensively in recent literature and will not be further discussed in this perspective [23,30,33,34]. Herein, we focus on synthetically useful biocatalytic reactions employing two liquid phases, in an effort to highlight the beneﬁts and limitations associated with droplet microﬂuidics when used to perform these reactions. Before we discuss speciﬁc examples of two-phase biocatalysis in droplets, we offer a relevant introduction into the production technology of droplet microﬂuidics. 3.2. Production Technology of Droplet Microﬂuidics Droplet formation methods can be classiﬁed as passive or active. Passive methods primarily use microchannel architecture and ﬂow rates to control the formation of droplets, while active methods employ external force ﬁelds (e.g., light, electricity). In droplet-based biocatalysis, active droplet formation methods are generally avoided as the used external force ﬁelds could harm the enzymes or cells used to facilitate the reactions. The most common passive hydrodynamic methods used to produce microdroplets can be categorized into three groups according to the microchannel architecture: T-junction, ﬂow-focusing, and co-ﬂowing devices. The geometry of the intersection where the two ﬂows meet, the ﬂow rate of each phase and the properties of the ﬂuid (surface tension, viscosity, etc.) determine the local stresses that deform the liquid interface and cause droplet formation. T-junction: T-junctions were ﬁrst proposed by Thorsen et al. in 2001 [40]. Droplets in this device architecture are formed when two mutually immiscible ﬂuids meet at the T-shaped microchannel intersection. Under the action of pressure and shear, the continuous phase cuts off the dispersed phase to form droplets. As seen in Figure 3, T-junctions have a simple architecture and are easy to fabricate, which makes them a popular choice for applications in biocatalysis. However, the droplet width is determined by the width of the microﬂuidic channel, and therefore, spherical droplets with smaller diameters cannot be produced. This can be a limiting factor when using these devices for two-phase biocatalysis, as the available droplet surface area can be quite small compared to that of smaller droplets that ﬂoat in the middle of the channel. This can partly inhibit mass transfer across the droplet interface (e.g., diffusion of substrate from the organic to the aqueous phase), a critical step during biocatalysis. Figure 3. Droplet generation in a T-junction. Large droplets are formed in the channel, resulting in slug ﬂow. T-junctions, and similarly Y-junctions, have been the most commonly used microﬂuidic architectures to perform biphasic biocatalysis experiments. Some examples include work from Pohar et al., who used microﬂuidic devices of this architecture for the synthesis of isoamyl acetate [41], and Tušek et al., in which Y-junction microﬂuidic devices were used to study hexanol oxidation [42]. In the work of Tušek, two-phase biocatalysis was performed in a droplet microreactor and a cuvette under the same conditions. A kinetic model and a reactor model were established based on the results of the biotransformation. Comparing Biosensors 2021, 11, x FOR PEER REVIEW 5 of 14   Figure 3. Droplet generation in a T‐junction. Large droplets are formed in the channel, resulting in slug flow. T‐junctions, and similarly Y‐junctions, have been the most commonly used microflu‐idic architectures to perform biphasic biocatalysis experiments. Some examples include work from Pohar et al., who used microfluidic devices of this architecture for the synthesis of isoamyl acetate [41], and Tušek et al., in which Y‐junction microfluidic devices were used to study hexanol oxidation [42]. In the work of Tušek, two‐phase biocatalysis was performed in a droplet microreactor and a cuvette under the same conditions. A kinetic model and a reactor model were established based on the results of the biotransformation. Comparing the kinetic parameters estimated by the two measurements, the maximum reaction rate in the microreactor was estimated to be approximately 33 times higher than in the cuvette. Additionally, in the experiments performed in microfluidic droplets, al‐most no reaction inhibition or reverse reaction were observed. Flow focusing: The first micromachined flow‐focusing system was introduced in 2001 by Ganan‐Calvo et al. [43]. In 2003, Anna et al. used the flow‐focusing geometry to form microfluidic water droplets in oil (water‐in‐oil droplets) and oil droplets in water (oil‐in‐water droplets) [44]. To generate microfluidic droplets, the continuous phase is in‐jected into the microfluidic device through two side channels and is used to squeeze the dispersed phase, flowing through the central channel (Figure 4). The formation of micro‐fluidic droplets is also facilitated by geometric constraints, such as the introduction of an orifice (a neck). The flow‐focusing method can produce spherical microfluidic droplets with a diameter much smaller than the channel width.  Figure 4. Droplet generation in a flow‐focusing device. Small spherical droplets are formed in the channel resulting in droplet flow. The use of flow‐focusing microfluidic devices for two‐phase biocatalysis has been very limited despite the many advantages this method provides, such as controlled gen‐eration of spherical microdroplets (as opposed to ellipsoidal, see Figure 2), that float in the center of the channel, away from the walls, enabling mass transfer across the droplet interface. The only example of biocatalysis in flow focusing systems was published by Novak et al., who used this method for the synthesis of isoamyl acetate enzymes in mi‐crodroplets and the recovery of ionic liquids [45]. The use of microfluidic droplets enabled a significantly higher productivity of isoamyl acetate compared to the respective batch process. More details about this work can be found in Section 4. Biosensors 2021, 11, 407 5 of 13 the kinetic parameters estimated by the two measurements, the maximum reaction rate in the microreactor was estimated to be approximately 33 times higher than in the cuvette. Additionally, in the experiments performed in microﬂuidic droplets, almost no reaction inhibition or reverse reaction were observed. Flow focusing: The ﬁrst micromachined ﬂow-focusing system was introduced in 2001 by Ganan-Calvo et al. [43]. In 2003, Anna et al. used the ﬂow-focusing geometry to form microﬂuidic water droplets in oil (water-in-oil droplets) and oil droplets in water (oil-in-water droplets) [44]. To generate microﬂuidic droplets, the continuous phase is injected into the microﬂuidic device through two side channels and is used to squeeze the dispersed phase, ﬂowing through the central channel (Figure 4). The formation of microﬂuidic droplets is also facilitated by geometric constraints, such as the introduction of an oriﬁce (a neck). The ﬂow-focusing method can produce spherical microﬂuidic droplets with a diameter much smaller than the channel width. Figure 4. Droplet generation in a ﬂow-focusing device. Small spherical droplets are formed in the channel resulting in droplet ﬂow. The use of ﬂow-focusing microﬂuidic devices for two-phase biocatalysis has been very limited despite the many advantages this method provides, such as controlled generation of spherical microdroplets (as opposed to ellipsoidal, see Figure 2), that ﬂoat in the center of the channel, away from the walls, enabling mass transfer across the droplet interface. The only example of biocatalysis in ﬂow focusing systems was published by Novak et al., who used this method for the synthesis of isoamyl acetate enzymes in microdroplets and the recovery of ionic liquids [45]. The use of microﬂuidic droplets enabled a signiﬁcantly higher productivity of isoamyl acetate compared to the respective batch process. More details about this work can be found in Section 4. Co-ﬂowing: Co-ﬂowing is a method in which a capillary is embedded in a microchan- nel, and the dispersed and continuous phases ﬂow through the capillary and the microchan- nel, respectively [46]. Unlike ﬂow-focusing systems, co-ﬂowing channels do not have a “neck-like” structure. The continuous phase does not squeeze the dispersed phase, but it is itself squeezed around the dispersed phase (Figure 5). This causes a destabilization at the dispersed phase front, which causes it to break into microdroplets. The size of droplets generated in co-ﬂowing devices is controlled by the channel widths, the diameter of the cap- illary, and the ﬂow rates used in experiments. In general, the co-ﬂowing method produces well-controlled droplets with a diameter smaller than the width of the microﬂuidic channel. To date, no co-ﬂowing system has been used in two-phase biocatalysis, presumably due to the complicated droplet generation principle and device fabrication process. Figure 5. Droplet generation in a co-ﬂowing microﬂuidic system. Small spherical droplets are formed in the channel resulting in droplet ﬂow. Biosensors 2021, 11, x FOR PEER REVIEW 5 of 14   Figure 3. Droplet generation in a T‐junction. Large droplets are formed in the channel, resulting in slug flow. T‐junctions, and similarly Y‐junctions, have been the most commonly used microflu‐idic architectures to perform biphasic biocatalysis experiments. Some examples include work from Pohar et al., who used microfluidic devices of this architecture for the synthesis of isoamyl acetate [41], and Tušek et al., in which Y‐junction microfluidic devices were used to study hexanol oxidation [42]. In the work of Tušek, two‐phase biocatalysis was performed in a droplet microreactor and a cuvette under the same conditions. A kinetic model and a reactor model were established based on the results of the biotransformation. Comparing the kinetic parameters estimated by the two measurements, the maximum reaction rate in the microreactor was estimated to be approximately 33 times higher than in the cuvette. Additionally, in the experiments performed in microfluidic droplets, al‐most no reaction inhibition or reverse reaction were observed. Flow focusing: The first micromachined flow‐focusing system was introduced in 2001 by Ganan‐Calvo et al. [43]. In 2003, Anna et al. used the flow‐focusing geometry to form microfluidic water droplets in oil (water‐in‐oil droplets) and oil droplets in water (oil‐in‐water droplets) [44]. To generate microfluidic droplets, the continuous phase is in‐jected into the microfluidic device through two side channels and is used to squeeze the dispersed phase, flowing through the central channel (Figure 4). The formation of micro‐fluidic droplets is also facilitated by geometric constraints, such as the introduction of an orifice (a neck). The flow‐focusing method can produce spherical microfluidic droplets with a diameter much smaller than the channel width.  Figure 4. Droplet generation in a flow‐focusing device. Small spherical droplets are formed in the channel resulting in droplet flow. The use of flow‐focusing microfluidic devices for two‐phase biocatalysis has been very limited despite the many advantages this method provides, such as controlled gen‐eration of spherical microdroplets (as opposed to ellipsoidal, see Figure 2), that float in the center of the channel, away from the walls, enabling mass transfer across the droplet interface. The only example of biocatalysis in flow focusing systems was published by Novak et al., who used this method for the synthesis of isoamyl acetate enzymes in mi‐crodroplets and the recovery of ionic liquids [45]. The use of microfluidic droplets enabled a significantly higher productivity of isoamyl acetate compared to the respective batch process. More details about this work can be found in Section 4. Biosensors 2021, 11, x FOR PEER REVIEW 6 of 14  Co‐flowing: Co‐flowing is a method in which a capillary is embedded in a micro‐channel, and the dispersed and continuous phases flow through the capillary and the mi‐crochannel, respectively [46]. Unlike flow‐focusing systems, co‐flowing channels do not have a “neck‐like” structure. The continuous phase does not squeeze the dispersed phase, but it is itself squeezed around the dispersed phase (Figure 5). This causes a destabiliza‐tion at the dispersed phase front, which causes it to break into microdroplets. The size of droplets generated in co‐flowing devices is controlled by the channel widths, the diameter of the capillary, and the flow rates used in experiments. In general, the co‐flowing method produces well‐controlled droplets with a diameter smaller than the width of the microflu‐idic channel. To date, no co‐flowing system has been used in two‐phase biocatalysis, pre‐sumably due to the complicated droplet generation principle and device fabrication pro‐cess.  Figure 5. Droplet generation in a co‐flowing microfluidic system. Small spherical droplets are formed in the channel resulting in droplet flow. 3.3. Droplet Generation and the Use of Surfactants Droplet generation in microfluidic systems generally requires the use of surfactants, especially when droplets are generated using the flow‐focusing or co‐flowing methods. Surfactants are amphiphilic molecules commonly added to the continuous phase at small concentrations to promote the formation of new interfaces [47]. These molecules are ad‐sorbed at the liquid–liquid interface to promote droplet stabilization and prevent coales‐cence [48]. Therefore, the addition of surfactants is important for stable droplet generation and manipulation and can also affect droplet properties such as their size.  However, as these amphiphilic molecules line the interface between the aqueous and organic phase, i.e., the droplet perimeter, it is expected that they also play a key role in the control of molecular exchange across the interface. Indeed, the rate of solute transport across a droplet interface through a surfactant monolayer has been shown to depend on many parameters such as the solute and surfactant size and structure, the density of the monolayer, and the curvature of the interface [49]. As mass transport across the droplet interface is a critical step during biocatalysis, the choice of suitable surfactants is also crit‐ical for high conversion rates. Additionally, surfactants have been shown to affect the cat‐alytic activity of enzymes [50], and in turn, enzymes themselves can potentially serve as “surfactants” that stabilize droplet formation, as reported in the examples of lipase‐cata‐lyzed isoamyl acetate synthesis discussed in more detail below [41,45]. Most examples on biphasic biocatalysis in microreactors have relied on the use of polysorbate 20 (also known commercially as Tween 20) [28,50] or simply on the am‐phiphilic properties of the enzyme catalyst itself [41,51]. Previous work on enzyme evo‐lution in microdroplets has primarily relied on fluorinated polyethers as surfactants [52,53]. Apart from available synthetic surfactants, a broad range of biological surface‐active agents (biosurfactants) are also known today, ranging from various glycolipids or lipopeptides to surface‐active proteins (e.g., hydrophobins) [54–56]. Biosurfactants have found various applications in industry due to their high interface activity [57]; their use in microfluidic droplet stabilization remains however limited. 3.4. Microfluidic Device Materials When microfluidics are intended to host biotransformations, the choice of device ma‐terial is critical. Aspects such as surface tolerance to solvents, channel hydrophobicity and gas permeability need to be carefully considered. The materials most commonly used in Biosensors 2021, 11, 407 6 of 13 3.3. Droplet Generation and the Use of Surfactants Droplet generation in microﬂuidic systems generally requires the use of surfactants, especially when droplets are generated using the ﬂow-focusing or co-ﬂowing methods. Surfactants are amphiphilic molecules commonly added to the continuous phase at small concentrations to promote the formation of new interfaces [47]. These molecules are adsorbed at the liquid–liquid interface to promote droplet stabilization and prevent coales- cence [48]. Therefore, the addition of surfactants is important for stable droplet generation and manipulation and can also affect droplet properties such as their size. However, as these amphiphilic molecules line the interface between the aqueous and organic phase, i.e., the droplet perimeter, it is expected that they also play a key role in the control of molecular exchange across the interface. Indeed, the rate of solute transport across a droplet interface through a surfactant monolayer has been shown to depend on many parameters such as the solute and surfactant size and structure, the density of the monolayer, and the curvature of the interface [49]. As mass transport across the droplet interface is a critical step during biocatalysis, the choice of suitable surfactants is also critical for high conversion rates. Additionally, surfactants have been shown to affect the catalytic activity of enzymes [50], and in turn, enzymes themselves can potentially serve as “surfactants” that stabilize droplet formation, as reported in the examples of lipase-catalyzed isoamyl acetate synthesis discussed in more detail below [41,45]. Most examples on biphasic biocatalysis in microreactors have relied on the use of polysorbate 20 (also known commercially as Tween 20) [28,50] or simply on the amphiphilic properties of the enzyme catalyst itself [41,51]. Previous work on enzyme evolution in microdroplets has primarily relied on ﬂuorinated polyethers as surfactants [52,53]. Apart from available synthetic surfactants, a broad range of biological surface-active agents (biosurfactants) are also known today, ranging from various glycolipids or lipopeptides to surface-active proteins (e.g., hydrophobins) [54–56]. Biosurfactants have found various applications in industry due to their high interface activity [57]; their use in microﬂuidic droplet stabilization remains however limited. 3.4. Microﬂuidic Device Materials When microﬂuidics are intended to host biotransformations, the choice of device material is critical. Aspects such as surface tolerance to solvents, channel hydrophobicity and gas permeability need to be carefully considered. The materials most commonly used in the fabrication of microreactors are glass, polycarbonate, and polytetraﬂuoroethylene (PTFE). Glass has the advantage of good transparency, chemical stability, and good bio- compatibility. However, the fabrication of microchannels in glass requires expertise in microtechnology, as advanced processing using photolithography or laser microstructuring are necessary. Low entry manufacturing technologies such as 3D printing have also been investigated as they can be easily adopted by non-experts and used to create inexpensive devices [58]. However, the resolution that can be achieved using 3D printing methods such as stereolithography is limited (feature size in the order of a few hundred micrometers), and therefore, larger devices are produced, which requires a higher consumption of sample and reagents. Additionally, synthetic resins often display low tolerance against organic solvents. Polycarbonate offers the advantages of low cost, low water absorption, and good processing performance. It is the material of choice for microﬂuidics used in biomedical research and biological analysis, but its tendency to absorb some organic solvents makes it difﬁcult to use for two-phase biocatalysis applications. However, surface coatings offer a solution to this problem. Mohr et al. used polycarbonate-based microﬂuidics coated with a 25-µm ﬁlm of ﬂuorinated ethylene propylene to create a recirculating, two-phase ﬂow mi- crobioreactor. The ﬂuoropolymer coating was used to increase the chemical resistance and hydrophobicity of the microchannels [59]. Finally, PTFE offers inertness to chemicals and solvents, antifouling properties, moderate gas permeability, and low non-speciﬁc protein adsorption compared to polycarbonate. It is therefore widely used in the ﬁeld of biphasic biocatalysis, especially used in microreactors made from microcapillary tubing [60]. Biosensors 2021, 11, 407 7 of 13 4. Examples of Two-Phase Biocatalysis in Microdroplets Biocatalytic esteriﬁcations, redox reactions, and lyase-catalyzed conversions mak- ing use of two liquid phases of different polarity have been performed in microdroplets (see Figure 6). These biphasic biotransformations have been used to increase substrate concentration in the reaction, efﬁciently extract product into the non-aqueous phase for simpliﬁed downstream processing, or reduce substrate and/or product inhibition of the enzyme. In the following paragraphs, notable examples of two-phase biocatalysis in micro- droplets are discussed. These examples include work performed in both microfabricated reactors, as well as droplets generated in similar device architectures using microcapillaries (capillary-based microreactors). In 2009, Znidarsic–Plazl and coworkers reported the CalB-catalyzed synthesis of isoamyl acetate, a ﬂavor, and fragrance compound used in food, cosmetics, and pharma- ceutical industry, from isoamyl alcohol and acetic anhydride in a continuously-operated Ψ-shaped droplet microreactor made out of glass [41]. The employed two-phase sys- tem consisted of a water-miscible ionic liquid and n-heptane. While all reagents and the aqueous enzyme solution were suspended in the ionic liquid phase, the product (isoamyl acetate) was efﬁciently extracted into the hydrophobic organic phase. Using a 3:1 ratio of alcohol to acetic anhydride and a microﬂuidic ﬂow pattern that resulted in a combina- tion of long slugs (ellipsoidal droplets) and circulating ﬁne droplets of n-heptane in the continuous ionic liquid phase, enabled an almost 3-fold productivity increase compared to the respective batch process. This signiﬁcant improvement was mainly attributed to more efﬁcient mixing and hence a much higher interfacial area between liquids within the microchannel. When a ﬂow-focusing microﬂuidic chip was used for the same enzymatic reaction, uniform n-heptane droplets were formed in the ionic liquid phase [45]. This resulted in an even higher interfacial area, across which the reaction and product extraction takes place, with the amphiphilic lipase positioned at the ionic liquid-n-heptane interface. Moreover, the integration of a membrane-based phase separator allowed the reuse of the enzyme-containing ionic liquid over several cycles. In another approach, the performance of capillary microreactors with various inner diameters was compared, when Rhizomucor miehei lipase was used for the esteriﬁcation of oleic acid with 1-butanol for biodiesel production [60]. The aqueous phase containing the dissolved enzyme and the organic phase comprising fatty acids and butanol in n-heptane were introduced through a Y-junction resulting in a slug-ﬂow proﬁle. Two microreactor materials were used: hydrophobic PTFE or hydrophilic stainless steel. In PTFE channels, aqueous droplets were formed within the organic slug. In stainless steel channels, droplets of the organic phase were formed within the continuous aqueous phase. An increase in the volumetric organic-to-aqueous phase ﬂow ratio signiﬁcantly improved enzyme performance in the stainless steel microreactor in contrast to the PTFE-based one. This difference was explained by a larger increase in the interfacial area when the organic phase is moving through the continuous aqueous phase in the form of long droplets, as compared to the short aqueous droplets in a continuous organic phase observed in the PTFE-based microreactor [60]. Biosensors 2021, 11, 407 8 of 13 Figure 6. Biocatalytic two-phase reaction examples performed in microﬂuidic droplets. Biosensors 2021, 11, x FOR PEER REVIEW 8 of 14   Figure 6. Biocatalytic two‐phase reaction examples performed in microfluidic droplets. Biosensors 2021, 11, 407 9 of 13 Next to those biocatalytic esteriﬁcations, Koch et al. reported the successful formation of C-C bonds using crude lysates of two different hydroxynitrile lyases in specially de- signed microreactors [37]. Enzyme-catalyzed addition of HCN to different aldehydes using a two-liquid phase system under undeﬁned slug ﬂow in Y-shape microﬂuidics yielded α-cyanohydrins with excellent enantioselectivity. The organic phase made of MTBE con- tained the respective aldehyde, while the cyanide (in form of KCN) was provided via the enzyme-containing aqueous phase. The authors further demonstrated that this setup could be applied successfully for the screening of different reaction parameters using only minute amounts of reagents and a signiﬁcantly shorter time compared to batch experi- ments. As another example, the industrially relevant hydration of acrylonitrile by nitrile hydratase to form acrylamide was reported using a membrane dispersion, stainless steel microreactor [61]. In membrane dispersion microreactors, the two phases are separated by a membrane. Droplets are formed when one phase is pushed into the other through the membrane. In the work discussed here, acrylonitrile was added as a substrate to the con- tinuous aqueous phase, which contained whole Rhodococcus ruber TH3 cells as the catalyst. Membrane dispersion was used to produce acrylonitrile droplets with 25–35 µm diameter. The large surface area of these microdroplets signiﬁcantly enhanced mass transfer and led to high acrylamide concentration (45.8 wt%) within 35 min of reaction. Selected biocatalytic redox reactions in microﬂuidic droplets have also been reported, which utilize key advantages of microdroplets and have served as model systems for process optimization. Mohr and colleagues examined the performance of a promiscu- ous pentaerythritol tetranitrate reductase under anaerobic conditions in a recirculating continuous-ﬂow microbioreactor [59]. Coating the polycarbonate bioreactor walls with thick hydrophobic ﬂuoropolymer enabled the formation of stable aqueous droplets in isooctane using a T-junction. Installation of spectroscopic cells in the recirculating organic and aqueous channels allowed UV-spectroscopic reaction monitoring based on the ab- sorbance of the substrate/product and the NADPH cofactor. By implementing a NADPH recycling system in the aqueous phase, the authors also investigated the performance of the bioreactor when it comes to the reduction of selected oleﬁns. They found an improved performance compared to analogous reactions in batch, presumably due to a combination of increased mass transfer granted by a higher surface-to-volume ratio, as well as efﬁcient product removal from the aqueous phase. To further study mass transfer limitations in biphasic redox reactions, Buehler and coworkers examined the effect of various process variables on the reduction of 1-heptaldehyde by a thermophilic alcohol dehydrogenase [28]. An aqueous buffer containing the enzyme, the cofactor, and recycling system based on formate dehydrogenation was mixed with a hexadecane phase at a T-junction and formed slugs in the organic phase. The authors probed the effects of ﬂow rate, capillary diameter, phase ratio, as well as enzyme and substrate concentrations under segmented ﬂow con- ditions. By optimizing these parameters, the system could be tuned for efﬁcient enzyme usage, while maintaining high productivity. Remarkably, despite the enzyme’s inhibition at >1 mM substrate in the aqueous phase, the mass transfer optimization performed in this capillary system enabled the efﬁcient feeding of substrate and concurrent product removal, achieving product titers of almost 40 mM. In an additional study, the same authors utilized slugs formed in a capillary T-junction to address the low stability of the dehydrogenase under operational conditions [50]. Inactivation of the enzyme at the liquid interface was successfully eliminated through the application of low concentrations of Tween 20 as a surfactant, most likely via stabilization of the phase barrier. Finally, Zelic and colleagues used the reverse reaction as a model system for the evaluation of kinetic parameters in a continuously operated Y-shaped tubular microreactor [42]. Using Saccharomyces cerevisiae alcohol dehydrogenase, the authors examined the oxidation of hexanol in a biphasic system composed of buffer and hexane. Compared to batch experiments, the authors found a drastic increase in the reaction rate as well as a complete elimination of product inhibition. A further example comes from our own recent work, where we used ﬂow-focusing mi- to perform testosterone dehydrogenation catalyzed by the croﬂuidic devices Biosensors 2021, 11, 407 10 of 13 17β-hydroxysteroid dehydrogenase (17β-HSD) from Comamonas testosteroni [62] in mi- croﬂuidic droplets. Microﬂuidic devices were fabricated in glass using femtosecond laser ablation. The buffer solution containing the enzyme was used as the aqueous carrier phase and methyl tert-butyl ether (MTBE) containing testosterone was used as the organic phase conﬁned in the microdroplets. For reactions performed in microﬂuidics with 10 mM steroid concentration, a 91% conversion of testosterone to androstenedione was obtained in only 40 s of reaction time, resulting in a space-time yield (STY) of 234 g L−1 h−1. In comparison, respective batch reactions yielded 85% conversion after 10 min reaction time, resulting in a STY of only 14.6 g L−1 h−1. The works discussed above underscore the value of microdroplets in the testing and optimization of biphasic biocatalytic processes that typically suffer from product inhibition and low mass transfer rates. At the same time, many questions arise about the utility of droplet microreactors and the root of the underutilization of such systems in biocatalytic process design. 5. Conclusions and Future Perspective As presented in detail above, microﬂuidic systems offer a unique set of advantages that make them particularly suitable as reaction vessels for two-phase biocatalysis. These advantages include continuously operated reactions, short diffusion paths, and tremen- dously increased mass transfer rates. Biphasic biocatalytic processes have been reported in microﬂuidic devices, primarily ones utilizing laminar ﬂow conﬁgurations [38,39]. Despite the additional advantages offered by droplet-based microﬂuidics, such as dramatically increased surface-to-volume ratios, their use in two-phase biocatalysis remains limited. This is mainly due to the complexity associated with microﬂuidic device fabrication and the establishment of a stable droplet ﬂow. Commercial droplet generation and control systems (such as the Elveﬂow Microﬂuidic Droplet Pack) offer an out-of-the-box solution to this problem as their use requires no expertise in microtechnology. The few examples of two-phase biocatalysis in microdroplets discussed above primarily utilize simple T-, Y-, or Ψ-junctions to establish slugs [37,41,50,59,60]. Slug ﬂow can be realized at lower ﬂow rates compared to droplet ﬂow and does not typically require the use of surfactants or channel surface treatment. Additionally, slug ﬂow can be established in microcapillary tubes, making this method more accessible to researchers with no access to microfabrication facilities or specialized equipment. However, slugs usually have large, variable diameters that are difﬁcult to control. This means lower surface-area-to-volume ratio compared to microﬂuidic droplets generated in ﬂow-focusing systems and less controlled experiments. Flow-focusing devices have a relatively complicated architecture and droplet generation often requires device and process optimization. However, the droplets produced in these systems have a uniform, deﬁned spherical shape and a diameter that is smaller than the channel size. This ensures a large interfacial area between the two phases in biphasic biocatalysis, which in turn should lead to enhanced conversion and reaction rates because of increased mass transport across the interface. Stable microdroplets that do not coalesce usually require the use of a surfactant. Surfactants line the interface between the aqueous and organic phase, and it is thus expected that they would also control molecular exchange across the interface. On the other hand, as enzymes can be inactivated when in contact with organic solvents, the addition of surfactants could have a positive effect, by eliminating enzyme inactivation at the liquid-liquid interface as shown in one literature example [50]. Similarly, a large interfacial area between the aqueous and organic phases in microdroplet systems might introduce an additional risk for enzyme inactivation, as enzyme inactivation in liquid−liquid bubble column systems was found to be proportional to the interfacial area [63]. A large interfacial area is, however, a requirement for enhanced mass transfer. The tradeoff between maximized mass transfer and high enzyme inactivation rates in small droplets with large surface-to-volume ratios remains to be investigated, as it was never explicitly studied in droplet microﬂuidics. It should be noted here, however, that Biosensors 2021, 11, 407 11 of 13 such enzyme inactivation will largely depend on the solvent system used as well as the employed enzyme and it hence needs to be addressed on a case-by-case basis. To directly compare and evaluate the effectiveness of each method when employed in two-phase biocatalysis is a difﬁcult task. Although individual studies often compare results obtained in batch process to results obtained in droplet-based processes, a comparison between two-phase biocatalysis in batch, laminar ﬂow, slug ﬂow, and droplet ﬂow has not been performed. Nevertheless, comparisons between batch processes and droplet processes consistently show higher conversion in droplets, explained by enhanced mass transport, product removal (lower product inhibition), and reaction rates. As evident by the literature review and discussion in this manuscript, microﬂuidic droplets have the potential to improve biphasic biocatalysis but have so far been grossly underutilized. Biocatalytic reactions that are product inhibited could particularly beneﬁt from fast mass transfer that allows in situ product extraction into microdroplets. Similarly, reactions that are substrate inhibited beneﬁt from chemical compartmentalization and short diffusion paths. Although slow biocatalytic reactions might not be compatible with conventional continuous-ﬂow microﬂuidics due to the short liquid residence time in these devices (seconds to few minutes), longer channels, stationary reaction chambers, or the use of long capillaries offer alternatives that can make long reactions in microdroplets feasible. In summary, several questions related to the application of this technology in biocatal- ysis remain unanswered, including: - Which method of droplet generation produces the best results and why? - Which type of ﬂow (laminar, slug, droplet) can deliver the best results and why? - What are the effects of surfactants on biotransformation? - Is there a tradeoff between enzyme inactivation and enhanced mass transfer when the interfacial area increases? Answers to these questions would provide researchers with the tool kits necessary to make informed decisions about the most suitable technology to use for their reactions. This would lower the barrier for the adaptation of droplet microﬂuidics in biocatalysis laboratories and would fuel development in this direction. Author Contributions: Conceptualization, I.C. and L.X.; writing—original draft preparation, L.X., F.K., A.S. and I.C.; writing—review and editing, L.X., F.K., A.S. and I.C.; funding acquisition, I.C. All authors have read and agreed to the published version of the manuscript. Funding: This work has been carried out within the framework of the SMART BIOTECS alliance between the Technische Universität Braunschweig and the Leibniz Universität Hannover. This initiative is supported by the Ministry of Science and Culture (MWK) of Lower Saxony, Germany. L.X. was funded through the 12plus6 initiative at the Faculty of Mechanical Engineering at Technische Universität Braunschweig. Institutional Review Board Statement: Not applicable. Informed Consent Statement: Not applicable. Acknowledgments: We acknowledge support by the Open Access Publication Funds of Technische Universität Braunschweig. Conﬂicts of Interest: The authors declare no conﬂict of interest. References 1. 2. 3. Arnold, F.H. Directed Evolution: Bringing New Chemistry to Life. Angew. Chem. Int. Ed. 2018, 57, 4143–4148. [CrossRef] Bell, E.L.; Finnigan, W.; France, S.P.; Green, A.P.; Hayes, M.A.; Hepworth, L.J.; Lovelock, S.L.; Niikura, H.; Osuna, S.; Romero, E.; et al. Biocatalysis. Nat. Rev. Methods Primers 2021, 1, 46. [CrossRef] Sandoval, B.A.; Hyster, T.K. Emerging strategies for expanding the toolbox of enzymes in biocatalysis. Curr. Opin. Chem. Biol. 2020, 55, 45–51. [CrossRef] 4. Winkler, C.K.; Schrittwieser, J.H.; Kroutil, W. Power of Biocatalysis for Organic Synthesis. ACS Cent. Sci. 2021, 7, 55–71. [CrossRef] Chakrabarty, S.; Romero, E.O.; Pyser, J.B.; Yazarians, J.A.; Narayan, A.R.H. Chemoenzymatic Total Synthesis of Natural Products. 5. Acc. Chem. Res. 2021, 54, 1374–1384. [CrossRef] Biosensors 2021, 11, 407 12 of 13 6. 7. 8. Devine, P.N.; Howard, R.M.; Kumar, R.; Thompson, M.P.; Truppo, M.D.; Turner, N.J. Extending the application of biocatalysis to meet the challenges of drug development. Nat. Rev. Chem. 2018, 2, 409–421. [CrossRef] Stout, C.N.; Renata, H. Reinvigorating the Chiral Pool: Chemoenzymatic Approaches to Complex Peptides and Terpenoids. Acc. Chem. Res. 2021, 54, 1143–1156. [CrossRef] Fryszkowska, A.; Devine, P.N. Biocatalysis in drug discovery and development. Curr. Opin. Chem. Biol. 2020, 55, 151–160. [CrossRef] 9. Hughes, G.; Lewis, J.C. Introduction: Biocatalysis in Industry. Chem. Rev. 2018, 118, 1–3. [CrossRef] 10. Wu, S.; Snajdrova, R.; Moore, J.C.; Baldenius, K.; Bornscheuer, U.T. Biocatalysis: Enzymatic Synthesis for Industrial Applications. Angew. Chem. Int. Ed. 2021, 60, 88–119. [CrossRef] 11. Ni, Y.; Holtmann, D.; Hollmann, F. How Green is Biocatalysis? To Calculate is To Know. ChemCatChem 2014, 6, 930–943. [CrossRef] 12. Kaspar, F.; Stone, M.R.L.; Neubauer, P.; Kurreck, A. Route efﬁciency assessment and review of the synthesis of β-nucleosides via N-glycosylation of nucleobases. Green Chem. 2021, 23, 37–50. [CrossRef] 13. de María, P.; Hollmann, F. On the (Un)greenness of Biocatalysis: Some Challenging Figures and Some Promising Options. Front. Microbiol. 2015, 6, 1257. 14. Carrea, G. Biocatalysis in water-organic solvent two-phase systems. Trends Biotechnol. 1984, 2, 102–106. [CrossRef] 15. Bühler, B.; Bollhalder, I.; Hauer, B.; Witholt, B.; Schmid, A. Use of the two-liquid phase concept to exploit kinetically controlled multistep biocatalysis. Biotechnol. Bioeng. 2003, 81, 683–694. [CrossRef] 16. Antonini, E.; Carrea, G.; Cremonesi, P. Enzyme catalysed reactions in water—Organic solvent two-phase systems. Enzym. Microb. Technol. 1981, 3, 291–296. [CrossRef] 17. Oppermann, S.; Stein, F.; Kragl, U. Ionic liquids for two-phase systems and their application for puriﬁcation, extraction and 18. biocatalysis. Appl. Microbiol. Biotechnol. 2011, 89, 493–499. [CrossRef] Sheldon, R.A. Biocatalysis in Ionic Liquids. In Catalysis in Ionic Liquids: From Catalyst Synthesis to Application; The Royal Society of Chemistry: London, UK, 2014; pp. 20–43. ISBN 978-1-84973-603-9. 19. Brink, L.E.S.; Tramper, J.; Luyben, K.C.A.M.; Van ’t Riet, K. Biocatalysis in organic media. Enzym. Microb. Technol. 1988, 10, 736–743. [CrossRef] 20. Grundtvig, I.P.R.; Heintz, S.; Krühne, U.; Gernaey, K.V.; Adlercreutz, P.; Hayler, J.D.; Wells, A.S.; Woodley, J.M. Screening of organic solvents for bioprocesses using aqueous-organic two-phase systems. Biotechnol. Adv. 2018, 36, 1801–1814. [CrossRef] 21. Ghatorae, A.S.; Bell, G.; Halling, P.J. Inactivation of enzymes by organic solvents: New technique with well-deﬁned interfacial area. Biotechnol. Bioeng. 1994, 43, 331–336. [CrossRef] 22. Mathys, R.G.; Schmid, A.; Witholt, B. Integrated two-liquid phase bioconversion and product-recovery processes for the oxidation of alkanes: Process design and economic evaluation. Biotechnol. Bioeng. 1999, 64, 459–477. [CrossRef] 23. Žnidaršiˇc-Plazl, P. Let the Biocatalyst Flow. Acta Chim. Slov. 2021, 68, 1–16. [CrossRef] 24. Bolivar, J.M.; Wiesbauer, J.; Nidetzky, B. Biotransformations in microstructured reactors: More than ﬂowing with the stream? Trends Biotechnol. 2011, 29, 333–342. [CrossRef] 25. Burgahn, T.; Pietrek, P.; Dittmeyer, R.; Rabe, K.S.; Niemeyer, C.M. Evaluation of a Microreactor for Flow Biocatalysis by Combined Theory and Experiment. ChemCatChem 2020, 12, 2452–2460. [CrossRef] 26. Wohlgemuth, R.; Plazl, I.; Žnidaršiˇc-Plazl, P.; Gernaey, K.V.; Woodley, J.M. Microscale technology and biocatalytic processes: Opportunities and challenges for synthesis. Trends Biotechnol. 2015, 33, 302–314. [CrossRef] 27. Rabe, K.S.; Müller, J.; Skoupi, M.; Niemeyer, C.M. Cascades in Compartments: En Route to Machine-Assisted Biotechnology. Angew. Chem. Int. Ed. 2017, 56, 13574–13589. [CrossRef] 28. Karande, R.; Schmid, A.; Buehler, K. Miniaturizing Biocatalysis: Enzyme-Catalyzed Reactions in an Aqueous/Organic Segmented Flow Capillary Microreactor. Adv. Synth. Catal. 2011, 353, 2511–2521. [CrossRef] 29. Krühne, U.; Heintz, S.; Ringborg, R.; Rosinha, I.P.; Tufvesson, P.; Gernaey, K.V.; Woodley, J.M. Biocatalytic process development using microﬂuidic miniaturized systems. Green Process. Synth. 2014, 3, 23–31. [CrossRef] 30. Mair, P.; Gielen, F.; Hollfelder, F. Exploring sequence space in search of functional enzymes using microﬂuidic droplets. Curr. Opin. Chem. Biol. 2017, 37, 137–144. [CrossRef] 31. Colin, P.-Y.; Kintses, B.; Gielen, F.; Miton, C.M.; Fischer, G.; Mohamed, M.F.; Hyvönen, M.; Morgavi, D.P.; Janssen, D.B.; Hollfelder, F. Ultrahigh-throughput discovery of promiscuous enzymes by picodroplet functional metagenomics. Nat. Commun. 2015, 6, 10008. [CrossRef] 32. Kintses, B.; Hein, C.; Mohamed, M.F.; Fischlechner, M.; Courtois, F.; Lainé, C.; Hollfelder, F. Picoliter Cell Lysate Assays in Microﬂuidic Droplet Compartments for Directed Enzyme Evolution. Chem. Biol. 2012, 19, 1001–1009. [CrossRef] [PubMed] Stucki, A.; Vallapurackal, J.; Ward, T.R.; Dittrich, P.S. Droplet Microﬂuidics and Directed Evolution of Enzymes: An Intertwined Journey. Angew. Chemie Int. Ed. 2021, 1433–7851. [CrossRef] 33. 34. Žnidaršiˇc-Plazl, P. The Promises and the Challenges of Biotransformations in Microﬂow. Biotechnol. J. 2019, 14, 1800580. [CrossRef] 35. Badenhorst, C.P.S.; Bornscheuer, U.T. Droplet microﬂuidics: From simple activity screening to sophisticated kinetics. Chem 2021, 7, 835–838. [CrossRef] 36. Holland-Moritz, D.A.; Wismer, M.K.; Mann, B.F.; Farasat, I.; Devine, P.; Guetschow, E.D.; Mangion, I.; Welch, C.J.; Moore, J.C.; Sun, S.; et al. Mass Activated Droplet Sorting (MADS) Enables High-Throughput Screening of Enzymatic Reactions at Nanoliter Scale. Angew. Chemie Int. Ed. 2020, 59, 4470–4477. [CrossRef] Biosensors 2021, 11, 407 13 of 13 37. Koch, K.; van den Berg, R.J.F.; Nieuwland, P.J.; Wijtmans, R.; Schoemaker, H.E.; van Hest, J.C.M.; Rutjes, F.P.J.T. Enzymatic enantioselective C–C-bond formation in microreactors. Biotechnol. Bioeng. 2008, 99, 1028–1033. [CrossRef] 38. Meng, S.-X.; Xue, L.-H.; Xie, C.-Y.; Bai, R.-X.; Yang, X.; Qiu, Z.-P.; Guo, T.; Wang, Y.-L.; Meng, T. Enhanced enzymatic reaction by aqueous two-phase systems using parallel-laminar ﬂow in a double Y-branched microﬂuidic device. Chem. Eng. J. 2018, 335, 392–400. [CrossRef] 39. Bolivar, J.M.; Nidetzky, B. Multiphase biotransformations in microstructured reactors: Opportunities for biocatalytic process intensiﬁcation and smart ﬂow processing. Green Process. Synth. 2013, 2, 541–559. [CrossRef] 40. Thorsen, T.; Roberts, R.W.; Arnold, F.H.; Quake, S.R. Dynamic pattern formation in a vesicle-generating microﬂuidic device. Phys. Rev. Lett. 2001, 86, 4163–4166. [CrossRef] [PubMed] 41. Pohar, A.; Plazl, I.; Žnidaršiˇc–Plazl, P. Lipase-catalyzed synthesis of isoamyl acetate in an ionic liquid/n–heptane two-phase system at the microreactor scale. Lab Chip 2009, 9, 3385–3390. [CrossRef] [PubMed] 42. Tušek, A.; Šali´c, A.; Kurtanjek, Ž.; Zeli´c, B. Modeling and kinetic parameter estimation of alcohol dehydrogenase-catalyzed hexanol oxidation in a microreactor. Eng. Life Sci. 2012, 12, 49–56. [CrossRef] 43. Gañán-Calvo, A.M.; Gordillo, J.M. Perfectly monodisperse microbubbling by capillary ﬂow focusing. Phys. Rev. Lett. 2001, 87, 274501. [CrossRef] [PubMed] 44. Anna, S.; Bontoux, N.; Stone, H. Formation of dispersions using “ﬂow focusing” in microchannels. Appl. Phys. Lett. 2003, 82, 364–366. [CrossRef] 45. Novak, U.; Žnidaršiˇc-Plazl, P. Integrated lipase-catalyzed isoamyl acetate synthesis in a miniaturized system with enzyme and ionic liquid recycle. Green Process. Synth. 2013, 2, 561–568. [CrossRef] 46. Cramer, C.; Fischer, P.; Windhab, E.J. Drop formation in a co-ﬂowing ambient ﬂuid. Chem. Eng. Sci. 2004, 59, 3045–3058. [CrossRef] Seemann, R.; Brinkmann, M.; Pfohl, T.; Herminghaus, S. Droplet based microﬂuidics. Rep. Prog. Phys. 2012, 75, 16601. [CrossRef] 47. 48. Baret, J.-C. Surfactants in droplet-based microﬂuidics. Lab Chip 2012, 12, 422–433. [CrossRef] 49. Ahn, Y.N.; Gupta, A.; Chauhan, A.; Kopelevich, D.I. Molecular Transport through Surfactant-Covered Oil−Water Interfaces: Role of Physical Properties of Solutes and Surfactants in Creating Energy Barriers for Transport. Langmuir 2011, 27, 2420–2436. [CrossRef] 50. Karande, R.; Schmid, A.; Buehler, K. Enzyme Catalysis in an Aqueous/Organic Segment Flow Microreactor: Ways to Stabilize Enzyme Activity. Langmuir 2010, 26, 9152–9159. [CrossRef] 51. Novak, U.; Lavric, D.; Žnidaršiˇc-Plazl, P. Continuous lipase B-catalyzed isoamyl acetate synthesis in a two-liquid phase system using corning® AFRTM module coupled with a membrane separator enabling biocatalyst recycle. J. Flow Chem. 2016, 6, 33–38. [CrossRef] Fallah-Araghi, A.; Baret, J.-C.; Ryckelynck, M.; Grifﬁths, A.D. A completely in vitro ultrahigh-throughput droplet-based microﬂu- idic screening system for protein engineering and directed evolution. Lab Chip 2012, 12, 882–891. [CrossRef] [PubMed] 52. 53. Obexer, R.; Godina, A.; Garrabou, X.; Mittl, P.R.E.; Baker, D.; Grifﬁths, A.D.; Hilvert, D. Emergence of a catalytic tetrad during evolution of a highly active artiﬁcial aldolase. Nat. Chem. 2017, 9, 50–56. [CrossRef] [PubMed] 54. Ron, E.Z.; Rosenberg, E. Natural roles of biosurfactants. Environ. Microbiol. 2001, 3, 229–236. [CrossRef] [PubMed] 55. Sunde, M.; Pham, C.L.L.; Kwan, A.H. Molecular Characteristics and Biological Functions of Surface-Active and Surfactant Proteins. Annu. Rev. Biochem. 2017, 86, 585–608. [CrossRef] [PubMed] 56. Linder, M.B.; Szilvay, G.R.; Nakari-Setälä, T.; Penttilä, M.E. Hydrophobins: The protein-amphiphiles of ﬁlamentous fungi. FEMS 57. Microbiol. Rev. 2005, 29, 877–896. [CrossRef] Santos, D.K.F.; Ruﬁno, R.D.; Luna, J.M.; Santos, V.A.; Sarubbo, L.A. Biosurfactants: Multifunctional Biomolecules of the 21st Century. Int. J. Mol. Sci. 2016, 17, 401. [CrossRef] 58. Grösche, M.; Zoheir, A.E.; Stegmaier, J.; Mikut, R.; Mager, D.; Korvink, J.G.; Rabe, K.S.; Niemeyer, C.M. Microﬂuidic Chips for Life Sciences-A Comparison of Low Entry Manufacturing Technologies. Small 2019, 15, e1901956. [CrossRef] 59. Mohr, S.; Fisher, K.; Scrutton, N.S.; Goddard, N.J.; Fielden, P.R. Continuous two-phase ﬂow miniaturised bioreactor for monitoring anaerobic biocatalysis by pentaerythritol tetranitrate reductase. Lab Chip 2010, 10, 1929–1936. [CrossRef] 60. Hommes, A.; de Wit, T.; Euverink, G.J.W.; Yue, J. Enzymatic Biodiesel Synthesis by the Biphasic Esteriﬁcation of Oleic Acid and 1-Butanol in Microreactors. Ind. Eng. Chem. Res. 2019, 58, 15432–15444. [CrossRef] 61. Li, J.; Chen, J.; Wang, Y.; Luo, G.; Yu, H. Hydration of acrylonitrile to produce acrylamide using biocatalyst in a membrane dispersion microreactor. Bioresour. Technol. 2014, 169, 416–420. [CrossRef] 62. Benach, J.; Filling, C.; Oppermann, U.C.T.; Roversi, P.; Bricogne, G.; Berndt, K.D.; Jörnvall, H.; Ladenstein, R. Structure of Bacterial 3β/17β-Hydroxysteroid Dehydrogenase at 1.2 Å Resolution: A Model for Multiple Steroid Recognition. Biochemistry 2002, 41, 14659–14668. [CrossRef] [PubMed] 63. Ghatorae, A.S.; Guerra, M.J.; Bell, G.; Halling, P.J. Immiscible organic solvent inactivation of urease, chymotrypsin, lipase, and ribonuclease: Separation of dissolved solvent and interfacial effects. Biotechnol. Bioeng. 1994, 44, 1355–1361. [CrossRef] [PubMed]